Table 3.
Ghrelin* | GIP | GLP-1 | Glucagon | Insulin* | Leptin | PAI-1* | Resistin | Visfatin* | |
---|---|---|---|---|---|---|---|---|---|
BS/TS | −0.6366 | 0.485 | 0.205 | −0.171 | −0.541 | − 0.334 | −0.67 | − 0.222 | −1.615 |
(− 1.11- -0.154) | (− 0.081–1.052) | (− 0.388 - 0.799) | (−0.495–0.152) | (− 0.958 – − 0.123) | (−0.903–0.235) | (−1.020 – − 0.321) | (−1.00–0.555) | (−2.51 – − 0.713) | |
Age (years) | 0.0032 | 0.027 | 0.014 | 0.013 | −0.012 | − 0.014 | −0.027 | 0.344 | 0.007 |
(−0.235–0.030) | (− 0.003–0.059) | (− 0.018 - 0.047) | (−0.004–0.031) | (− 0.035-0.010) | (−0.046–0.172) | (−0.047 – − 0.008) | (−0.008–0.077) | (−0.042–0.058 | |
BMI | −0.006 | − 0.01 | −0.016 | − 0.011 | 0.014 | 0.035 | 0.001 | −0.017 | −0.007 |
(−0.44–0.032) | (−0.005–0.034) | (− 0.064–0.030) | (− 0.037-0.014) | (−0.019–0.047) | (−0.009–0.080) | (− 0.026 - 0.028) | (−0.079–0.044) | (−0.791–0.064) | |
MS | − 0.089 | −0.022 | − 0.321 | 0.0004 | 0.014 | 0.479 | 0.01 | −0.458 | −0.576 |
(−0.514–0.336) | (−0.557–0.477) | (− 0.845–0.202) | (−0.289–0.280) | (−0.353–0.382) | (−0.022–0.981) | (−0.297–0.318) | (−1.144–0.228) | (−1.372–0.219) | |
FEV1%p | −0.006 | 0.001 | 0 | 0 | −0.001 | 0.001 | 0.005 | −0.013 | 0 |
(−0.018–0.005) | (−0.012–0.015) | (− 0.014 - 0.149) | (−0.007–0.008) | (− 0.011 - 0.009) | (−0.012–0.015) | (−0.003–0.013) | (−0.032–0.006) | (−0.023–0.021) |
Multiple comparisons analysis was perform by the statistical software XLSTAT 2016.5 Addinsoft. *P < 0.05
Abbreviations: BMI Body mass index, GIP gastric inhibitory polypeptide, GLP-1 glucagon-like peptide-1, MS Metabolic syndrome, PAI-1 plasminogen activator inhibitor-1, TS tobacco smoking